Erectile Dysfunction With Diabetes Mellitus
10
3
3
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
10.0%
1 terminated out of 10 trials
66.7%
-19.8% vs benchmark
20%
2 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (10)
Mesenchymal Stem Cell and Exosome Therapy for Diabetic Erectile Dysfunction
Combining Shockwave Therapy and Platelet Rich Plasma to Treat Erectile Dysfunction in Diabetic Men (COCKTAIL-DM)
Evaluation of Efficacy of Botulinum Toxin A Plus Oral Tadalafil 5 mg in Diabetic Men With Erectile Dysfunction
Impact of Glycemic Control on Penile Duplex Results
Genetic Factors of Erectile Dysfunction Degree and Response to Tadalafil Treatment in Patients With Diabetes
Using of Testes' Shocker in Improving Sexual Activity
Penile Implant Intraoperative Measurements Planning Chart
Serum YKL-40 Level and Platelets Indices Among Patients With Diabetic Erectile Dysfunction
The Outcomes of Intracavernosal Umbilical Cord Mesenchymal Stem Cells Implantation in Patients With Diabetic Erectile Dysfunction
Evaluation of Drug Interactions of Saxagliptin With Sildenafil in Healthy Volunteers